Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zhongyuan Union Cell & Gene Eng
AddedFeb 20, 2024
UpdatedJun 28, 2026
Zhongyuan Union Cell & Gene Eng

Zhongyuan Union Cell & Gene Eng

Public

Leading stem cell detection and storage provider.

HQ
Tianjin, Guangdong, CN
Founded
1992
Overview
Compare
Employees

Zhongyuan Union Cell & Gene Eng focuses on the detection and storage of stem cell sources. Their core mission is to advance stem cell technology and provide reliable storage solutions, aiming to support medical research and therapeutic applications. The company primarily serves the healthcare and biotechnology markets.

The company has made significant strides in stem cell technology, contributing to advancements in medical research and treatments. Their innovative solutions have positioned them as a leader in the field, impacting both scientific progress and patient care.

Zhongyuan Union Cell & Gene Eng - Similar Companies

StemSave logo

StemSave

stemsave.com

Stemcyte logo

Stemcyte

stemcyte.com

Personalized Stem Cells logo

Personalized Stem Cells

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

MitoStem logo

MitoStem

RhinoCyte logo

RhinoCyte

rhinocyte.com

Next Healthcare logo

Next Healthcare

Life Ark logo

Life Ark

lifeark.io

Stem Cell Reserve logo

Stem Cell Reserve

AdiCyte logo

AdiCyte

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Stemgenics logo

Stemgenics

stemgenics.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Cell Vault logo

Cell Vault

cellvault.com

LaCell logo

LaCell

Zhongyuan Union Cell & Gene Eng - Quick Facts

Who are Zhongyuan Union Cell & Gene Eng's competitors?

Companies similar to Zhongyuan Union Cell & Gene Eng include StemSave, Stemcyte, Personalized Stem Cells and Celltex Therapeutics.

When was Zhongyuan Union Cell & Gene Eng founded?

Zhongyuan Union Cell & Gene Eng was founded in 1992.

Where is Zhongyuan Union Cell & Gene Eng's headquarters located?

Zhongyuan Union Cell & Gene Eng's headquarters is located in Tianjin, Guangdong, CN.

How many employees does Zhongyuan Union Cell & Gene Eng have?

Zhongyuan Union Cell & Gene Eng has 3,000 employees as of Feb 10, 2024.

Zhongyuan Union Cell & Gene Eng - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Stem Cell Storage
Tags
  • Data
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified